Physician in the Loop: Internal Medicine

Retatrutide given weekly cut mean body weight 25.0% at the highest dose over 80 weeks in adults with obesity, a phase 3 trial published Sept. 29 in The New England Journal of Medicine reported. A second trial in The Lancet reported 18.8% loss at that dose in adults with obesity and type 2 diabetes. Six physician groups including the American College of Physicians (ACP) criticized statements suggesting AI is better informed than physicians, and the Centers for Medicare & Medicaid Services (CMS) finalized a Part B drug pricing model.

Read this week's roundup and its sources: https://physicianintheloop.org/specialties/internal-medicine/2026-09-28/

The voices on this episode are generated by AI, and so is the script, from the week's specialty roundup at Physician in the Loop. Every fact in the roundup links to its source.